Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Reperfusion Injury | 6 | 2016 | 20 | 1.560 |
Why?
|
| Resuscitation | 3 | 2015 | 69 | 1.130 |
Why?
|
| Heart Valve Prosthesis | 3 | 2015 | 61 | 0.590 |
Why?
|
| Swine | 7 | 2016 | 230 | 0.520 |
Why?
|
| Bioprosthesis | 2 | 2015 | 62 | 0.520 |
Why?
|
| Glycoproteins | 1 | 2015 | 44 | 0.460 |
Why?
|
| Antibodies | 1 | 2015 | 59 | 0.460 |
Why?
|
| Antigens, CD | 1 | 2015 | 106 | 0.450 |
Why?
|
| Bioengineering | 1 | 2015 | 77 | 0.440 |
Why?
|
| Heart Valves | 2 | 2011 | 16 | 0.440 |
Why?
|
| Peptides | 1 | 2015 | 142 | 0.440 |
Why?
|
| Atmospheric Pressure | 2 | 2013 | 11 | 0.420 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 435 | 0.370 |
Why?
|
| Tissue Engineering | 3 | 2011 | 700 | 0.340 |
Why?
|
| Myocardial Ischemia | 1 | 2010 | 114 | 0.300 |
Why?
|
| Animals | 12 | 2016 | 8544 | 0.290 |
Why?
|
| Sheep | 3 | 2015 | 233 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 1118 | 0.210 |
Why?
|
| Fructose | 1 | 2003 | 12 | 0.200 |
Why?
|
| Myocytes, Cardiac | 2 | 2013 | 97 | 0.170 |
Why?
|
| Myocardial Infarction | 3 | 2013 | 515 | 0.170 |
Why?
|
| Time Factors | 4 | 2016 | 2352 | 0.170 |
Why?
|
| Peroxidase | 2 | 2015 | 31 | 0.160 |
Why?
|
| Bioreactors | 2 | 2010 | 61 | 0.150 |
Why?
|
| Myocardium | 2 | 2015 | 199 | 0.120 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2016 | 11 | 0.120 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2016 | 58 | 0.120 |
Why?
|
| Fluid Shifts | 1 | 2016 | 4 | 0.120 |
Why?
|
| Edema, Cardiac | 1 | 2016 | 14 | 0.120 |
Why?
|
| Extracellular Fluid | 1 | 2016 | 17 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2016 | 76 | 0.120 |
Why?
|
| Vimentin | 1 | 2015 | 11 | 0.120 |
Why?
|
| Actins | 1 | 2015 | 56 | 0.120 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 37 | 0.110 |
Why?
|
| beta Catenin | 1 | 2015 | 39 | 0.110 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 95 | 0.110 |
Why?
|
| Prosthesis Design | 1 | 2015 | 116 | 0.110 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2015 | 56 | 0.110 |
Why?
|
| Heart | 1 | 2016 | 191 | 0.110 |
Why?
|
| Echocardiography | 1 | 2015 | 202 | 0.110 |
Why?
|
| Coronary Vessels | 1 | 2015 | 180 | 0.100 |
Why?
|
| Endocardium | 1 | 2013 | 5 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 260 | 0.100 |
Why?
|
| Myocardial Reperfusion | 1 | 2013 | 10 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 593 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2016 | 887 | 0.100 |
Why?
|
| Pericardium | 1 | 2013 | 55 | 0.100 |
Why?
|
| Insulin Resistance | 2 | 2006 | 488 | 0.090 |
Why?
|
| Female | 4 | 2016 | 21491 | 0.090 |
Why?
|
| Biomedical Engineering | 1 | 2011 | 28 | 0.090 |
Why?
|
| Apoptosis | 1 | 2013 | 400 | 0.090 |
Why?
|
| Heterocyclic Compounds | 1 | 2010 | 16 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2010 | 23 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 84 | 0.080 |
Why?
|
| Doxorubicin | 1 | 2010 | 91 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 75 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 70 | 0.080 |
Why?
|
| Contrast Media | 1 | 2010 | 148 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 184 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 1386 | 0.070 |
Why?
|
| Rats, Zucker | 2 | 2006 | 5 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2009 | 203 | 0.070 |
Why?
|
| Rats | 3 | 2010 | 1946 | 0.060 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2006 | 3 | 0.060 |
Why?
|
| Insulin | 1 | 2003 | 394 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2003 | 529 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 923 | 0.040 |
Why?
|
| Diet | 1 | 2003 | 418 | 0.040 |
Why?
|
| Obesity | 1 | 2006 | 1244 | 0.040 |
Why?
|
| Diffusion | 1 | 2016 | 17 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 2016 | 17 | 0.030 |
Why?
|
| Cell Shape | 1 | 2016 | 30 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 2016 | 17 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 49 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 44 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2016 | 143 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 259 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 128 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 83 | 0.030 |
Why?
|
| Male | 3 | 2010 | 20697 | 0.030 |
Why?
|
| Gadolinium | 1 | 2010 | 22 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 62 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 102 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 287 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 934 | 0.020 |
Why?
|
| Decanoic Acids | 1 | 2006 | 1 | 0.020 |
Why?
|
| Diazoxide | 1 | 2006 | 1 | 0.020 |
Why?
|
| KATP Channels | 1 | 2006 | 1 | 0.020 |
Why?
|
| Hydroxy Acids | 1 | 2006 | 2 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2006 | 10 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 43 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2010 | 440 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2006 | 10 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2006 | 19 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2006 | 57 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 48 | 0.020 |
Why?
|
| Mitochondrial Membranes | 1 | 2006 | 27 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2006 | 80 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2006 | 69 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 281 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 174 | 0.010 |
Why?
|
| Humans | 1 | 2010 | 34475 | 0.000 |
Why?
|